Under construction – not a live service
Sign in
CompletedNo phase

Opioid Reduction in Orthopaedic Surgery (OREOS) - Knees

Key facts

Who runs it
Kim Madden
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
102 people enrolled
Started
9 Mar 2022
Ended
14 Jul 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Multicomponent opioid reduction and pain management pathway
  • Standard care
Record updated
3 December 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Adult (18+)
  • Undergoing elective total knee arthroplasty (TKA) for knee arthritis
  • Can use a simple electronic (phone or tablet) device
  • Provide informed consent to participate

Who cannot take part

  • Revision surgery
  • Simultaneous bilateral arthroplasties
  • Unable to consent (e.g., cognitive disability or substantial language barrier without a support person)

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Knee replacements are the second most common surgery in Canada. Most patients recover very well but research consistently shows that 1 in 5 patients still have pain many months after surgery. Doctors often prescribe opioid medications for pain after surgery (e.g. Percocet, hydromorphone, codeine). These medications can be helpful for some people, but they can also be dangerous, particularly when used for a long time. Many patients don't like the way opioids make them feel and would prefer alternative pain management strategies. Some people become addicted to opioids, have a difficult time reducing the dose of opioids, or have lasting health problems after using them.

Read full original descriptionShow less

People in this study will be randomized to either have usual care or a new pathway designed to improve pain control and decrease opioid use after knee replacements. This study will have an intervention coordinator who will assess patients before surgery and who will follow up with patients regularly after surgery to make sure their pain is controlled and to avoid long-term opioid use. This study will use education, physiotherapy, psychological therapy, ice/cold, and non-opioid pain medications. As pain medications may work differently in different patients, the coordinator will check on each patient to look for pain control and assist to reduce the amount of opioids used after surgery.

This study will help people have safer and more effective pain management after surgery which may lead to better recovery, higher satisfaction, and a lower risk of being harmed by opioids after surgery.

The 2 groups in the trial

  • Standard care groupExisting treatment, for comparison

    This group will receive standard perioperative care, surgical treatment, and pain medications.

    Treatment: Standard care

  • Opioid reduction groupTreatment being tested

    Patients will participate in a multicomponent pathway coordinated by a trained coordinator who will facilitate patient participation and engagement with each interventional component.

    Treatment: Multicomponent opioid reduction and pain management pathway

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Opioid Reduction in Orthopaedic Surgery (OREOS): a Feasibility Randomized Controlled Trial in Knee Replacement Patients
Record updated
3 December 2024